Del-Sette Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.11M | Buy |
+63,843
| New | +$3.11M | 2.16% | 22 |
|
|
2024
Q3 | – | Sell |
-36,841
| Closed | -$1.99M | – | 36 |
|
|
2024
Q2 | $1.99M | Buy |
+36,841
| New | +$1.99M | 1.63% | 20 |
|
|
2023
Q4 | – | Sell |
-33,977
| Closed | -$1.54M | – | 29 |
|
|
2023
Q3 | $1.54M | Buy |
33,977
+316
| +0.9% | +$14.3K | 1.52% | 16 |
|
|
2023
Q2 | $1.89M | Buy |
33,661
+9,867
| +41% | +$554K | 1.79% | 16 |
|
|
2023
Q1 | $1.08M | Buy |
+23,794
| New | +$1.08M | 1.06% | 20 |
|